Israeli company's COVID-19 drug shows promise in late-stage coronavirus treatment

FIRST ON FOX: An Israeli public company says it developed the "only cure for late-stage COVID" and said that the results of its phase II clinical trial, disclosed first to Fox News, revealed that patients suffering from severe cases of COVID-19 had a 94% survival rate after being treated with the drug.

from Fox News https://ift.tt/3xk3DpY